BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15059536)

  • 1. [Expression of connexin in atrium of patients with atrial fibrillation and its signal transduction pathway].
    Yan H; Chen JZ; Zhu JH; Ni YM; Yu GW; Hu SJ; Tao QM
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):209-13. PubMed ID: 15059536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between connexins and atrial activation during human atrial fibrillation.
    Kanagaratnam P; Cherian A; Stanbridge RD; Glenville B; Severs NJ; Peters NS
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):206-16. PubMed ID: 15028052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relation between angiotensin II receptors 1 and 2, and CYP11B2 and atrial structural remodeling in patients with atrial fibrillation].
    Wu YQ; Wang XD; Fang H; Wang YL; Zhang YC; Su LJ
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2281-4. PubMed ID: 18001553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of mineralocorticoid receptor and 11-beta-hydroxysteroid dehydrogenase type 2 in human atria during chronic atrial fibrillation: study of 25 cases].
    Pei DA; Li L; Xu ZY; Zou LJ; Zhang BR; Huang SD; Hao JH; Wang ZN; Lu FL
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):816-9. PubMed ID: 17565863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the spatial distribution pattern of Cx40 gap junctions in the atria of patients with coronary heart disease.
    Zhou SH; He XZ; Liu QM; Du WH; Li XP; Zhou T; Tang JQ; Li RS
    Cardiol J; 2008; 15(1):50-6. PubMed ID: 18651385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
    Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relationship between gap junctional remodeling and atrial fibrillation in patients with rheumatic heart disease].
    Li DQ; Feng YB; Zhang HQ
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):384-6. PubMed ID: 15061990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of angiotensin converting enzyme inhibitor on the expression of angiotensin converting enzyme 2 in atrium of patients with atrial fibrillation].
    Hu XS; Xie XD; Wang XX; Zeng CL; Ni YM; Yu GW; Chen JZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):625-8. PubMed ID: 17961427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in gelatinases expression and activity in human atria during atrial fibrillation].
    Ke D; Xu CX; Zhang JC; Chen L; Lin YZ; Lin LF; Hu XZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):137-42. PubMed ID: 15924808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies.
    Wetzel U; Boldt A; Lauschke J; Weigl J; Schirdewahn P; Dorszewski A; Doll N; Hindricks G; Dhein S; Kottkamp H
    Heart; 2005 Feb; 91(2):166-70. PubMed ID: 15657225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression.
    Goette A; Bukowska A; Lendeckel U; Erxleben M; Hammwöhner M; Strugala D; Pfeiffenberger J; Röhl FW; Huth C; Ebert MP; Klein HU; Röcken C
    Circulation; 2008 Feb; 117(6):732-42. PubMed ID: 18227384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs.
    Sarrazin JF; Comeau G; Daleau P; Kingma J; Plante I; Fournier D; Molin F
    J Am Coll Cardiol; 2007 Oct; 50(15):1505-12. PubMed ID: 17919572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation.
    Cong H; Li X; Ma L; Jiang H; Mao Y; Xu M
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):298-304. PubMed ID: 20080265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-specific remodeling in atrial fibrillation?
    Pfannmüller B; Boldt A; Reutemann A; Duerrschmidt N; Krabbes-Graube S; Mohr FW; Dhein S
    Thorac Cardiovasc Surg; 2013 Jan; 61(1):66-73. PubMed ID: 23315605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gap junction and Na+-H+ exchanger alternations in fibrillating and failing atrium.
    hui Y; junzhu C; jianhua Z
    Int J Cardiol; 2008 Aug; 128(1):147-9. PubMed ID: 17655944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm.
    Nao T; Ohkusa T; Hisamatsu Y; Inoue N; Matsumoto T; Yamada J; Shimizu A; Yoshiga Y; Yamagata T; Kobayashi S; Yano M; Hamano K; Matsuzaki M
    Am J Cardiol; 2003 Mar; 91(6):678-83. PubMed ID: 12633797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
    Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT
    J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial gap junctions, NF-kappaB and fibrosis in patients undergoing coronary artery bypass surgery: the relationship with postoperative atrial fibrillation.
    Li JY; Lai YJ; Yeh HI; Chen CL; Sun S; Wu SJ; Lin FY
    Cardiology; 2009; 112(2):81-8. PubMed ID: 18580064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.
    Burstein B; Comtois P; Michael G; Nishida K; Villeneuve L; Yeh YH; Nattel S
    Circ Res; 2009 Dec; 105(12):1213-22. PubMed ID: 19875729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma.
    Givant-Horwitz V; Davidson B; Goderstad JM; Nesland JM; Tropé CG; Reich R
    Gynecol Oncol; 2004 May; 93(2):517-23. PubMed ID: 15099972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.